Burzynski Research Institute, Inc. (BZYR)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -523.78 Thousand | -249.51 Thousand | -325.09 Thousand | -394.36 Thousand | -530.11 Thousand | -477.51 Thousand |
| Net Income | -1.33 Million | -916.29 Thousand | -976.65 Thousand | -1.2 Million | -1.63 Million | -1.63 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 799.87 Thousand | 654.29 Thousand | 695.28 Thousand | 916.47 Thousand | 1.13 Million | 1.08 Million |
| Change in working capital | 11.77 Thousand | 12.48 Thousand | -43.72 Thousand | -9072.00 | -34.6 Thousand | 79.15 Thousand |
| Other non-cash items | 799.87 Thousand | 653.63 Thousand | 694.59 Thousand | 817.78 Thousand | 1.13 Million | 1.07 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 524.15 Thousand | 247.06 Thousand | 328.41 Thousand | 394.26 Thousand | 529.56 Thousand | 477.71 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 524.15 Thousand | 247.06 Thousand | - | - | - | - |
| Other Financing Activities | 524.15 Thousand | 247.06 Thousand | 328.41 Thousand | 394.26 Thousand | 529.56 Thousand | 477.71 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3560.00 | 12.57 Thousand | -32.51 Thousand | -28.29 Thousand | -40.26 Thousand | 59.12 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 15.33 Thousand | -12.57 Thousand | -11.21 Thousand | 19.22 Thousand | 5654.00 | 20.02 Thousand |
| Cash at beginning of period | 934.00 | 3382.00 | 62.00 | 163.00 | 708.00 | 506.00 |
| Cash at end of period | 1310.00 | 934.00 | 3382.00 | 62.00 | 163.00 | 708.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 376.00 | -2448.00 | 3320.00 | -101.00 | -545.00 | 202.00 |
| Free Cash Flow | -523.78 Thousand | -249.51 Thousand | -325.09 Thousand | -394.36 Thousand | -530.11 Thousand | -477.51 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.33 Million | -362.9 Thousand | -433.01 Thousand | -252.1 Thousand | -287.4 Thousand | -916.29 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 799.87 Thousand | 234.6 Thousand | 202.05 Thousand | 197.12 Thousand | 166.09 Thousand | 654.29 Thousand |
| Change in working capital | 11.77 Thousand | -9314.00 | 29.87 Thousand | -64.79 Thousand | 56 Thousand | 12.48 Thousand |
| Other non-cash items | 799.87 Thousand | 234.6 Thousand | 201.84 Thousand | 196.93 Thousand | 165.93 Thousand | 653.63 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 524.15 Thousand | 138.01 Thousand | 200.6 Thousand | 121.01 Thousand | 64.51 Thousand | 247.06 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 524.15 Thousand | - | - | - | 64.51 Thousand | 247.06 Thousand |
| Other Financing Activities | 524.15 Thousand | 138.01 Thousand | 200.6 Thousand | 121.01 Thousand | 64.51 Thousand | 247.06 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3560.00 | -10.99 Thousand | 20 Thousand | -22.75 Thousand | 10.18 Thousand | 12.57 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 15.33 Thousand | 1676.00 | 9874.00 | -42.03 Thousand | -10.18 Thousand | -12.57 Thousand |
| Cash at beginning of period | 934.00 | 913.00 | 1397.00 | 148.00 | 934.00 | 3382.00 |
| Cash at end of period | 1310.00 | 1310.00 | 913.00 | 1397.00 | 148.00 | 934.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 376.00 | 397.00 | -484.00 | 1249.00 | -786.00 | -2448.00 |
| Free Cash Flow | -523.78 Thousand | -137.62 Thousand | -201.08 Thousand | -119.76 Thousand | -65.3 Thousand | -249.51 Thousand |
ZEEL
NEWD
UMBF
002900
HAG
STI